Skip to main content
Premium Trial:

Request an Annual Quote

National Jewish Health Partners with LabCorp on Molecular Dx

NEW YORK (GenomeWeb News) – Denver research hospital National Jewish Health will collaborate with Laboratory Corporation of America to develop and commercialize molecular diagnostic tests for respiratory, immune, and related diseases, the hospital said today.
 
The hospital and LabCorp have “established a framework for discovery, development, and commercialization of diagnostic tests,” National Jewish Health said.
 
Gary Smith, director of National Jewish Health’s Advanced Diagnostics Laboratory, said in a statement that the collaboration “will allow us to provide specialized companion diagnostic tools to a much broader audience."
 
Financial terms of the agreement were not disclosed.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.